[1]
Carratù, P., Dragonieri, S. and Resta, O. 2019. Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial. Swiss Medical Weekly. 149, 3940 (Sep. 2019), w20132. DOI:https://doi.org/10.4414/smw.2019.20132.